We haven't been able to take payment
You must update your payment details via My Account or by clicking update payment details to keep your subscription.
Update payment details
Act now to keep your subscription
We've tried to contact you several times as we haven't been able to take payment. You must update your payment details via My Account or by clicking update payment details to keep your subscription.
Update payment details
Your subscription is due to terminate
We've tried to contact you several times as we haven't been able to take payment. You must update your payment details via My Account, otherwise your subscription will terminate.
Update payment details

Accessibility Links

Skip to content
The Times & The Sunday Times
The Times & The Sunday Times
  • Subscribe
Subscribe

Rumour of the day

The Times
The Times

Provexis, the AIM-listed developer of functional and medical foods, shed 18p to 8½p, despite word that it is in talks to license its Fruitflow technology to Nestlé, the Swiss foodmaker. This month Provexis launched Sirco, its heart health drink, in Britain, its first product to utililise the patented Fruitflow system, which the company claims reduces the risk of heart attacks and strokes.